Edit
Indalo Therapeutics
http://www.indalotherapeutics.com/Last activity: 20.12.2019
Probably Closed
Indalo Therapeutics, a preclinical biotechnology company dedicated to developing therapies for fibrosis, is formed with an experienced team, strong IP, and robust portfolio of drug candidates. Learn more at www.indalotherapeutics.com.
Location: United States, Missouri, Saint Louis
Investors 3
Mentions in press and media 3
| Date | Title | Description |
| 20.12.2019 | Bill Lundberg takes over the reins at Merus; Former Akcea COO Jeffrey Goldberg takes the helm of Immunitas | Bill Lundberg → Dutch biotech Merus, who struck up a $200 million bispecific development deal with Incyte in 2016, is losing their CEO Ton Logtenberg. Meanwhile, the company has nominated Sven (Bill) Ante Lundberg to be Lo... |
| 01.02.2019 | Richard Pascoe takes the helm at Histogen; Lonza COO steps up at CEO Richard Ridinger retires | Richard Pascoe → Having handed off troubled microcap biotech Apricus Biosciences to Seelos Therapeutics via a merger, Richard Pascoe is moving on to his next CEO (and chairman) gig at Histogen. The regenerative medic... |
| 28.01.2019 | The FDA is back in business; Allogene given the green signal to test lymphoma drug in humans | → FDA commish Scott Gottlieb was spreading the love Monday morning, welcoming back FDA staff and looking to get the world’s fastest drug regulatory agency back up to full swing ASAP. Of course, it could all come crashing to a ... |